The effects of Shenkang suppository on kidney function and gut microbiota in nondialysis patients with chronic kidney disease stages 3–4: A randomized controlled trial

BackgroundChronic kidney disease (CKD) patients have high prevalence and mortality rates; however, current treatment options remain limited. The Shenkang suppository (SKS) is a traditional Chinese medicine used in the clinical management of CKD. Increasing evidence suggests a close relationship betw...

Full description

Saved in:
Bibliographic Details
Main Authors: Weiwei Zhang, Xin Zhang, Shuang Xu, Yousuf Abdulkarim Waheed, Yizhou Xu, Shulin Li, Dong Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1621208/full
Tags: Add Tag
No Tags, Be the first to tag this record!